A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials.
Over a tenth of breast cancer diagnoses are for triple-negative breast cancer. Triple-negative breast cancer (TNBC) gets its name because it lacks three common targets: estrogen, progesterone, and HER2. It disproportionately affects young women, especially African American women, making it an urgent priority for new treatment strategies.
Mississippi has higher-than-average rates of triple-negative breast cancer. According to a 2024 study from the University of Mississippi Medical Center, 37 % of breast cancer patients treated there between 2016 and 2023 were triple-negative, more than double the national norm.
The aggressive character of this cancer, along with its resistance to several common therapies, results in a greater fatality rate than other cancers.
While this cancer may not increase the levels of usual drug targets, the Ole Miss research team discovered a unique technique to deliver cancer therapies directly to cancer cells.
It doesn’t have any of the usual targets we’ve developed therapies for. That means we really had to think creatively about how to treat it. One thing that is consistent across all of the patients (with triple-negative breast cancer) is that they overexpress glucose transporters to bring more sugars to the cells. Essentially, it has a sweet tooth. So, how can we get it to take its medicine? We wrap it in sugar.
Eden Tanner, Assistant Professor, Chemistry and Biochemistry, The University of Mississippi
Tanner explained that by covering the nanoparticle cancer treatment with sugar, the researchers essentially “trick” the cancer into taking the drug.
When these sugar-coated cancer therapies are put into the bloodstream, they can “hitch a ride” on red and white blood cells. The drug goes through the body like a bus, eventually becoming stuck by the cancer’s glucose transporters.
Because triple-negative breast cancer cells overexpress GLUT-transporters, there is more of an affinity between the nanoparticles and those cells. This method could provide something that will change the way we treat this cancer in the future, and in a way that won’t affect our regular, healthy cells.
Ole Miss junior Mira Patel, co-author of the study.
Triple-negative breast cancer is not the only disease that overexpresses glucose transporters; so, the drug delivery strategy might be applied to treat other diseases.
We haven’t tested the technology on those other diseases yet, but there’s a good reason to believe that a similar strategy might work. That is exciting news for diseases like colon cancer, brain cancer, and fatty liver disease, which also have high levels of glucose transporters.
Eden Tanner, Assistant Professor, Chemistry and Biochemistry, The University of Mississippi
However, the researchers must evaluate the delivery mechanism under disease settings before it can be implemented. Their findings have the potential to save lives in Mississippi since triple-negative breast cancer is so common there.
Journal Reference:
Dasanayake, G. S. et al. (2025) Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple-Negative Breast Cancer Drug Delivery. Advanced Healthcare Materials. doi.org/10.1002/adhm.202500592
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
